These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. End-stage crystalline maculopathy with retinal atrophy in Sjögren-Larsson syndrome: a case report and review of the literature. Lambert LH; Shaikh N; Marx JL; Ramsey DJ Ther Adv Rare Dis; 2022; 3():26330040221122496. PubMed ID: 37180414 [TBL] [Abstract][Full Text] [Related]
4. Genotype and phenotype variability in Sjögren-Larsson syndrome. Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562 [TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337 [TBL] [Abstract][Full Text] [Related]
6. Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation. Amr K; El-Bassyouni HT; Ismail S; Youness E; El-Daly SM; Ebrahim AY; El-Kamah G Arch Dermatol Res; 2019 Nov; 311(9):721-730. PubMed ID: 31388754 [TBL] [Abstract][Full Text] [Related]
7. Compound heterozygous mutations in the Liu YD; Lin HJ; Li CY; Sun GF; Hu XB; Ma MY; Sun Y; Feng BZ; Li QB; Kong QX Int J Neurosci; 2020 Nov; 130(11):1156-1160. PubMed ID: 31944864 [No Abstract] [Full Text] [Related]
8. Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects. Abdel-Hamid MS; Issa MY; Elbendary HM; Abdel-Ghafar SF; Rafaat K; Hosny H; Girgis M; Abdel-Salam GMH; Zaki MS J Hum Genet; 2019 Sep; 64(9):859-865. PubMed ID: 31273323 [TBL] [Abstract][Full Text] [Related]
9. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes. Davis K; Holden KR; S'Aulis D; Amador C; Matheus MG; Rizzo WB J Child Neurol; 2013 Oct; 28(10):1259-65. PubMed ID: 23034980 [TBL] [Abstract][Full Text] [Related]
10. Novel ALDH3A2 mutations in structural and functional domains of FALDH causing diverse clinical phenotypes in Sjögren-Larsson syndrome patients. Rajeshwari M; Karthi S; Singh R; Efthymiou S; Gowda VK; Varalakshmi P; Srinivasan VM; Houlden H; Keller MA; Rizzo WB; Ashokkumar B Hum Mutat; 2021 Aug; 42(8):1015-1029. PubMed ID: 34082469 [TBL] [Abstract][Full Text] [Related]
11. Untargeted Metabolomic Analysis of Sjögren-Larsson Syndrome Reveals a Distinctive Pattern of Multiple Disrupted Biochemical Pathways. Dai HD; Qiu F; Jackson K; Fruttiger M; Rizzo WB Metabolites; 2023 May; 13(6):. PubMed ID: 37367841 [TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome. Cho KH; Shim SH; Kim M Clin Genet; 2018 Apr; 93(4):721-730. PubMed ID: 28543186 [TBL] [Abstract][Full Text] [Related]
15. A Turkish family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation. Incecık F; Herguner OM; Rizzo WB; Altunbasak S Ann Indian Acad Neurol; 2013 Jul; 16(3):425-7. PubMed ID: 24101836 [TBL] [Abstract][Full Text] [Related]
17. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation. Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264 [TBL] [Abstract][Full Text] [Related]